These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 8393497)
1. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497 [TBL] [Abstract][Full Text] [Related]
2. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse. Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732 [TBL] [Abstract][Full Text] [Related]
3. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related]
4. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats. Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700 [TBL] [Abstract][Full Text] [Related]
5. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Funada M; Suzuki T; Narita M; Misawa M; Nagase H Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722 [TBL] [Abstract][Full Text] [Related]
6. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Takahashi M; Senda T; Kaneto H Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330 [TBL] [Abstract][Full Text] [Related]
10. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676 [TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat. Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165 [TBL] [Abstract][Full Text] [Related]
12. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
13. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Suh HW; Song DK; Choi SR; Chung KM; Kim YH Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]
15. Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice. Narita M; Suzuki T; Misawa M; Nagase H Psychopharmacology (Berl); 1993; 110(1-2):254-6. PubMed ID: 7870894 [TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. Millan MJ; Członkowski A; Lipkowski A; Herz A J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers. Pruhs RJ; Peña RT; Quock RM Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior. Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637 [TBL] [Abstract][Full Text] [Related]
19. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Brent PJ Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839 [TBL] [Abstract][Full Text] [Related]
20. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat. Diop L; Rivière PJ; Pascaud X; Junien JL Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]